Trontinemab

SEP 10, 2026 · PHASE 3 TRIAL

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; the study is actively recruiting and designed to evaluate trontinemab in preclinical Alzheimer's disease, but outcome data are not yet available.

AUG 6, 2026 · PHASE 3 TRIAL

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

ClinicalTrials.gov

This is a registry record of an ongoing Phase 3 trial with no results posted; the study is recruiting and outcomes have not yet been reported.

AUG 6, 2026 · PHASE 3 TRIAL

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

ClinicalTrials.gov

This is a clinical trial registry record for a Phase 3 study that is actively recruiting; no results are reported, making this a description of planned research rather than evidence of efficacy or safety.